Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging

Technology in Cancer Research and Treatment

Volumn 3, Issue 6, 2004, Pages 557-565

  Law, Meng ^a   Hamburger, Micole ^a   Johnson, Glyn ^a   Inglese, Matilde ^a   Londono, Ana ^a   Golfinos, John ^b   Zagzag, David ^a   Knopp, Edmond A ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebral infarct; High grade glioma; Perfusion MR Imaging; Proton MR Spectroscopy (1H MRS); Tumefactive demyelinating lesion

Indexed keywords

CHOLINE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ABSCESS; ADULT; ANXIETY; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN CANCER; CANCER DIAGNOSIS; CANCER GRADING; CASE REPORT; CEREBRAL ARTERY DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; DEMYELINATING DISEASE; EMOTIONALITY; FEMALE; FINANCIAL MANAGEMENT; GLIOMA; HISTOPATHOLOGY; HUMAN; INFLAMMATION; ISCHEMIA; MALE; METABOLITE; METASTASIS; MORBIDITY; MORTALITY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION; REVIEW; SURGICAL TECHNIQUE;

EID: 11144267253     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460400300605     Document Type: Review

References (48)

1. Law, M., Yang, S., Wang, H. et al. Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging. AJNR Am. J. Neuroradiol. 24, 1989-1998 (2003).
2. Alger, J. R., Frank, J. A., Bizzi, A. et al. Metabolism of Human Gliomas: Assessment with H-1 MR Spectroscopy and F-18 Fluorodeoxyglucose PET. Radiology 177, 633-641 (1990).
3. Castillo, M. Proton MR Spectroscopy in Neoplastic and Non-Neoplastic Brain Disorders. MRI Clinics of North America 6, 1-19 (1998).
4. Castillo, M. and Kwock, L. Clinical Applications of Pro-ton Magnetic Resonance Spectroscopy in the Evaluation of Common Intracranial Tumors. Top Magn. Reson. Imaging 10, 104-113 (1999).
5. Kwock, L., Smith, J. K., Castillo, M. et al. Clinical Applications of Proton MR Spectroscopy in Oncology. Technol Cancer Res Treat 1, 17-28 (2002).
6. Negendank, W. G., Sauter, R., Brown, T. R. et al. Proton Magnetic Resonance Spectroscopy in Patients with Glial Tumors: A Multicenter Study. J. Neurosurg. 84, 449-458 (1996).
7. Law, M., Cha, S., Knopp, E. A., Johnson, G., Arnett, J., and Litt, A. W. High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging. Radiology 222, 715-721 (2002).
8. Ricci, P. E., Pitt, A., Keller, P. J., Coons, S. W., and Heiserman, J. E. Effect of Voxel Position on Single-voxel MR Spectroscopy Findings. AJNR Am. J. Neuroradiol. 21, 367-374. (2000).
9. Saunders, D. E. MR Spectroscopy in Stroke. Br. Med. Bull. 56, 334-345 (2000).
10. Cha, S., Knopp, E. A., Johnson, G., Wetzel, S. G., Litt, A. W., and Zagzag, D. Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging. Radiology 223, 11-29 (2002).
11. Cha, S. Perfusion MR Imaging: Basic Principles and Clinical Applications. Magn. Reson. Imaging Clin. N. Am. 11, 403-413 (2003).
12. Knopp, E. A., Cha, S., Johnson, G. et al. Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging. Radiology 211, 791-798 (1999).
13. Law, M., Yang, S., Babb, J. S. et al. Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-enhanced Perfusion MR Imaging with Glioma Grade. AJNR Am. J. Neuroradiol. 25, 746-755 (2004).
14. Warmuth, C., Gunther, M., and Zimmer, C. Quantification of Blood Flow in Brain Tumors: Comparison of Arterial Spin Labeling and Dynamic Susceptibility-weighted Contrast-enhanced MR Imaging. Radiology 228, 523-532 (2003).
15. Albayrak, S., Zhao, Q., Siesjo, B. K., and Smith, M. L. Effect of Transient Focal Ischemia on Blood Brain Barrier Permeability in the Rat: Correlation to Cell Injury. Acta. Neuropathol. 94, 158-163 (1997).
16. Harris, N. G., Gauden, V., Fraser, P. A., Williams, S. R., and Parker, G. J. MRI Measurement of Blood-brain Barrier Permeability Following Spontaneous Reperfusion in the Starch Microsphere Model of Ischemia. Magn. Reson. Imaging 20, 221-230 (2002).
17. Plutaa, R., Lossinskyb, A. S., Winiewskib, H. M., and Mossakowski, M. J. Early blood-brain Barrier Changes in the Rat Following Transient Complete Cerebral Ischemia Induced by Cardiac Arrest. Brain Research 633, 41-52 (1994).
18. Sorensen, A. G., Buonanno, F. S., Gonzalez, R. G. et al. Hyperacute Stroke: Evaluation with Combined Multisection Diffusion-weighted and Hemodynamically Weighted Echo-planar MR Imaging. Radiology 199, 391-401 (1996).
19. Moller-Hartmann, W., Herminghaus, S., Krings, T. et al. Clinical Application of Proton Magnetic Resonance Spectroscopy in the Diagnosis of Intracranial Mass Lesions. Neuroradiology 44, 371-381 (2002).
20. Fulham, M. J., Bizzi, A., Dietz, M. J. et al. Mapping of Brain Tumor Metabolites with Proton MR Spectroscopic Imaging: Clinical Relevance. Radiology 185, 675-686 (1992).
21. Tzika, A. A., Zarifi, M. K., Goumnerova, L. et al. Neuroimaging in Pediatric Brain Tumors: Gd-DTPA-enhanced, Hemodynamic, and Diffusion MR Imaging Compared with MR Spectroscopic Imaging. AJNR Am. J. Neuroradiol. 23, 322-333. (2002).
22. Yang, D., Korogi, Y., Sugahara, T. et al. Cerebral Gliomas: Prospective Comparison of Multivoxel 2D Chemical-shift Imaging Proton MR Spectroscopy, Echoplanar Perfusion, and Diffusion-weighted MRI. Neuroradiology 44, 656-666 (2002).
23. Castillo, M. and Kwock, L. Proton MR Spectroscopy of Common Brain Tumors. Neuroimaging Clin. N. Am. 8, 733-752 (1998).
24. Kwock, L. A. Tuning in on Tumor Activity with Proton MR Spectroscopy. Ajnr: American Journal of Neuroradiology 22, 807-808 (2001).
25. Fountas, K. N., Kapsalaki, E. Z., Gotsis, S. D. et al. In Vivo Proton Magnetic Resonance Spectroscopy of Brain Tumors. Stereotact Funct Neurosurg 74, 83-94 (2000).
26. Shimizu, H., Kumabe, T., Shirane, R., and Yoshimoto, T. Correlation Between Choline Level Measured by Proton MR Spectroscopy and Ki-67 labeling index in Gliomas. AJNR Am. J. Neuroradiol. 21, 659-665 (2000).
27. Shimizu, H., Kumabe, T., Tominaga, T. et al. Noninvasive Evaluation of Malignancy of Brain Tumors with Proton MR Spectroscopy. AJNR Am. J. Neuroradiol. 17, 737-747 (1996).
28. Sorensen, A. G., Copen, W. A., Ostergaard, L. et al. Hyperacute Stroke: Simultaneous Measurement of Relative Cerebral Blod Volume, Relalative Cerebral Blood Flow, and Mean Transit Time. Radiology 210 (1999).
29. Sorensen, A. G. and Reimer, P. Cerbral MR Perfusion Imaging: Principles and Current Applications. New York: Thieme (2000).
30. Karonen, J., Liu, Y., Vanninen, R. et al. Combined Perfusion-and Diffusion-weighted MR Imaging in Acute Ischemic Stroke during the 1st Week: A Longitudinal Study. Radiology 217, 886-894 (2000).
31. Vajkoczy, P. and Menger, M. D. Vascular Microenvironment in Gliomas. J. Neurooncol. 50, 99-108 (2000).
32. Karonen, J., Vanninen, R. L., Liu, Y. et al. Combined Diffusion and Perfusion MRI with Correlation to Single-photon Emission CT in Acute Ischemic Stroke: Ischemic Penumbra Predicts Infarct Growth. Stroke 30, 1583-1590 (1999).
33. Hatazawa, J., Shimosegawa, E., Toyoshima, H. et al. Cerebral Blood Volume in Acute Brain Infarction: A Combined Study with Dynamic Susceptibility Contrast MRI and 99 mTc-HMPAO-SPECT. Stroke 30, 800-806 (1999).
34. Crosby, D., Simonson, T., Fisher, D. et al. Echo-planar MR Imaging: Correlation of Intracranial Perfusion-sensitive Imaging with Cerebral Angiography. Society of Magnetic Resonance 277 (1994).
35. Cha, S., Pierce, S., Knopp, E. A. et al. Dynamic Contrast-enhanced T2*-weighted MR Imaging of Tumefactive Demyelinating Lesions. AJNR Am. J. Neuroradiol. 22, 1109-1116 (2001).
36. Saindane, A. M., Cha, S., Law, M., Xue, X., Knopp, E. A., and Zagzag, D. Proton MR Spectroscopy of Tumefactive Demyelinating Lesions. AJNR Am. J. Neuroradiol. 23, 1378-1386 (2002).
37. Law, M., Meltzer, D. E., and Cha, S. Spectroscopic Magnetic Resonance Imaging of a Tumefactive Demyelinating Lesion. Neuroradiology 44, 986-989 (2002).
38. Arnold, D. L., Matthews, P. M., Francis, G. S., O'Connor, J., and Antel, J. P. Proton Magnetic Resonance Spectroscopic Imaging for Metabolic Characterization of Demyelinating Plaques. Ann. Neurol. 31, 235-241 (1992).
39. Bitsch, A., Bruhn, H., Vougioukas, V. et al. Inflammatory CNS Demyelination: Histopathologic Correlation with In Vivo Quantitative Proton MR Spectroscopy. AJNR Am. J. Neuroradiol. 20, 1619-1627 (1999).
40. Davie, C. A., Hawkins, C. P., Barker, G. J. et al. Serial Proton Magnetic Resonance Spectroscopy in Acute Multiple Sclerosis Lesions. Brain 117 (Pt 1), 49-58 (1994).
41. Silva, H. C., Callegaro, D., Marchiori, P. E., Scaff, M., and Tsanaclis, A. M. Magnetic Resonance Imaging in Five Patients with a Tumefactive Demyelinating Lesion in the Central Nervous System. Arq. Neuropsiquiatr. 57, 921-926 (1999).
42. Kwock, L., Castillo, M., and Smith, J. K. Comparison of Proton MR Spectral Patterns of Glioblastoma Multiforme (GBM) Versus Metastatic Brain Tumors. In Proceedings of the Annual Meeting of the American Society of Neuroradiology, pp. 58. San Diego, CA (1999).
43. Preul, M. C., Caramanos, Z., Collins, D. L. et al. Accurate, Noninvasive Diagnosis of Human Brain Tumors by Using Proton Magnetic Resonance Spectroscopy. Nat. Med. 2, 323-325 (1996).
44. Ishimaru, H., Morikawa, M., Iwanaga, S., Kaminogo, M., Ochi, M., and Hayashi, K. Differentiation Between High-grade Glioma and Metastatic Brain Tumor Using Single-voxel Proton MR Spectroscopy. Eur. Radiol. 11, 1784-1791 (2001).
45. Burger, P. C. Classification, Grading, and Patterns of Spread of Malignant Gliomas. In Neurosurgical topics: malignant cerebral glioma, pp. 3-17. Ed. Apuzzo. In America Association of Neurological Surgeons. Park Ridge, Ill (1990).
46. Burger, P. C., Vogel, F. S., Green, S. B., and Strike, T. A. Glioblastoma Multiforme and Anaplastic Astrocytoma: Pathologic Criteria and Prognostic Implications. Cancer 56, 1106-1111 (1985).
47. Bhujwalla, Z. M., Artemov, D., Natarajan, K., Solaiyappan, M., Kollars, P., and Kristjansen, P. E. G. Reduction of Vascular and Permeable Regions in Solid Tumors Detected by Macromolecular Contrast Magnetic Resonance Imaging after Treatment with Antiangiogenic Agent TNP-470. Clin. Cancer. Res. 9, 355-362 (2003).
48. Cha, S., Knopp, E. A., Johnson, G. et al. Dynamic, Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin. American Journal of Neuroradiology 21, 881-890 (2000).